Published by Michele Maatouk on 16th July 2026
(Sharecast News) - Eli Lilly said on Thursday that it has agreed to buy AtaiBeckley, a clinical-stage biopharmaceutical company developing therapeutics for mental health conditions, for $2.8bn.
URL: http://www.digitallook.com/dl/news/story/36077021/...